Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1035420

'The 4th 90': a preliminary assessment of change in quality of life over 1 year of the EmERGE study: PROQOL-HIV and EQ-5D-5L, a descriptive analysis


Jones, C; Bremner, S; Leon, A; Begovac, Josip; Apers, L; Borges, M; Zekan, Šime; Teofilo, E; Garcia, F; Duracinsky, M; Whetham, J.
'The 4th 90': a preliminary assessment of change in quality of life over 1 year of the EmERGE study: PROQOL-HIV and EQ-5D-5L, a descriptive analysis // Hiv medicine, 20 (2019), Suppl.9; 211-211 (međunarodna recenzija, ostalo, znanstveni)


CROSBI ID: 1035420 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
'The 4th 90': a preliminary assessment of change in quality of life over 1 year of the EmERGE study: PROQOL-HIV and EQ-5D-5L, a descriptive analysis

Autori
Jones, C ; Bremner, S ; Leon, A ; Begovac, Josip ; Apers, L ; Borges, M ; Zekan, Šime ; Teofilo, E ; Garcia, F ; Duracinsky, M ; Whetham, J.

Izvornik
Hiv medicine (1464-2662) 20 (2019), Suppl.9; 211-211

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, ostalo, znanstveni

Ključne riječi
Preliminary assessment ; Quality ; Life ; EmERGE

Sažetak
Purpose: To assess the potential effect on Quality of Life (QoL) of a codesigned reduced visit pathway of care for individuals living with stable HIV. Methods: People living with stable HIV across five diverse clinical sites in Europe were invited to take part in the EmERGE study - whereby individuals are seen once instead of twice a year by their clinician - with interim visits supported via an mHealth platform. We report descriptively on QoL outcomes at baseline (M0) and month12 (M12) available to May 2019. For PROQOL-HIV, the mean change in score is reported by domain. For EQ-5D-5L, some vs. no problems (as proportions) are reported by dimension. Results: PROQOL-HIV was completed by N=1868/2230 (83.8%) at M0 and 966/1439 (69.2%) at M12. At M0, domain scores were generally high across sites (median score for each≥75/100), except for stigma (median=50, IQR 25.0–87.5) with some variation by site. Mean differences (M12-M0) for all domains were small relative to their SDs, indicating little change. Participants’ general health was good at M0, (2.4% rated their health as <fair) and at M12 had improved for N=151/912(16.6%), worsened for 261(28.6%), unchanged for 500 (54.8%). EQ-5D-5L was available on N=2115/2230 (95.5%) at M0, and N=1018/1439(70.1%) at M12. Mean health today was 84.3(SD=13.1), M0, and 83.4(SD=13.7), M12. At both M0&M12, >75% of respondents reported no problems with mobility, self-care or usual activities ; a smaller majority reported no pain/discomfort or anxiety/depression: proportions for these domains were lower (8.8%&6.6%, respectively) at M12. Conclusions: Preliminary results show QoL was high across PROQOL-HIV domains, except stigma, which scored lowest. Changes over time were small ; stigma improved at four out of five sites. QoL was similarly high on EQ-5D-5L dimensions. Observed reductions in general health and/or QoL may be explained by a ceiling effect in this healthy population with high QoL.

Izvorni jezik
Engleski



POVEZANOST RADA


Projekti:
108-1080116-0098 - Epidemiološka i klinička obilježja zaraze HIV-om u Hrvatskoj (Begovac, Josip, MZOS ) ( POIROT)

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Šime Zekan (autor)

Avatar Url Josip Begovac (autor)

Poveznice na cjeloviti tekst rada:

onlinelibrary.wiley.com

Citiraj ovu publikaciju:

Jones, C; Bremner, S; Leon, A; Begovac, Josip; Apers, L; Borges, M; Zekan, Šime; Teofilo, E; Garcia, F; Duracinsky, M; Whetham, J.
'The 4th 90': a preliminary assessment of change in quality of life over 1 year of the EmERGE study: PROQOL-HIV and EQ-5D-5L, a descriptive analysis // Hiv medicine, 20 (2019), Suppl.9; 211-211 (međunarodna recenzija, ostalo, znanstveni)
Jones, C., Bremner, S., Leon, A., Begovac, J., Apers, L., Borges, M., Zekan, Š., Teofilo, E., Garcia, F., Duracinsky, M. & Whetham, J. (2019) 'The 4th 90': a preliminary assessment of change in quality of life over 1 year of the EmERGE study: PROQOL-HIV and EQ-5D-5L, a descriptive analysis. Hiv medicine, 20 (Suppl.9), 211-211.
@article{article, author = {Jones, C and Bremner, S and Leon, A and Begovac, Josip and Apers, L and Borges, M and Zekan, \v{S}ime and Teofilo, E and Garcia, F and Duracinsky, M and Whetham, J.}, year = {2019}, pages = {211-211}, keywords = {Preliminary assessment, Quality, Life, EmERGE}, journal = {Hiv medicine}, volume = {20}, number = {Suppl.9}, issn = {1464-2662}, title = {'The 4th 90': a preliminary assessment of change in quality of life over 1 year of the EmERGE study: PROQOL-HIV and EQ-5D-5L, a descriptive analysis}, keyword = {Preliminary assessment, Quality, Life, EmERGE} }
@article{article, author = {Jones, C and Bremner, S and Leon, A and Begovac, Josip and Apers, L and Borges, M and Zekan, \v{S}ime and Teofilo, E and Garcia, F and Duracinsky, M and Whetham, J.}, year = {2019}, pages = {211-211}, keywords = {Preliminary assessment, Quality, Life, EmERGE}, journal = {Hiv medicine}, volume = {20}, number = {Suppl.9}, issn = {1464-2662}, title = {'The 4th 90': a preliminary assessment of change in quality of life over 1 year of the EmERGE study: PROQOL-HIV and EQ-5D-5L, a descriptive analysis}, keyword = {Preliminary assessment, Quality, Life, EmERGE} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font